Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	carbohydrate binding	ATRN MRC1 EGLN3 MRC2 GALNT9 EGLN1 GALNT12 ITLN2 CRYBG3 LY75	4.99e-07	310	81	10	GO:0030246
GeneOntologyMolecularFunction	apolipoprotein receptor activity	ABCA1 LRP1	4.86e-05	3	81	2	GO:0030226
GeneOntologyMolecularFunction	hypoxia-inducible factor-proline dioxygenase activity	EGLN3 EGLN1	9.70e-05	4	81	2	GO:0160082
GeneOntologyMolecularFunction	creatine transmembrane transporter activity	SLC16A9 SLC16A12	9.70e-05	4	81	2	GO:0005308
GeneOntologyMolecularFunction	peptidyl-proline 4-dioxygenase activity	EGLN3 EGLN1	4.48e-04	8	81	2	GO:0031545
Domain	RICIN	MRC1 MRC2 GALNT9 GALNT12 CRYBG3 LY75	1.78e-09	28	80	6	SM00458
Domain	RICIN_B_LECTIN	MRC1 MRC2 GALNT9 GALNT12 CRYBG3 LY75	1.78e-09	28	80	6	PS50231
Domain	Ricin_B_lectin	MRC1 MRC2 GALNT9 GALNT12 CRYBG3 LY75	2.79e-09	30	80	6	IPR000772
Domain	Ricin_B_lectin	MRC1 MRC2 GALNT9 GALNT12 CRYBG3	6.31e-08	25	80	5	PF00652
Domain	Ser/Thr-sp_prot-phosphatase	PPP2CA PPP2CB PPP6C	2.10e-05	13	80	3	IPR006186
Domain	SER_THR_PHOSPHATASE	PPP2CA PPP2CB PPP6C	2.10e-05	13	80	3	PS00125
Domain	PP2Ac	PPP2CA PPP2CB PPP6C	2.10e-05	13	80	3	SM00156
Domain	FN_type2_col-bd	MRC1 MRC2 LY75	2.66e-05	14	80	3	IPR000562
Domain	FN2_2	MRC1 MRC2 LY75	2.66e-05	14	80	3	PS51092
Domain	fn2	MRC1 MRC2 LY75	2.66e-05	14	80	3	PF00040
Domain	FN2_1	MRC1 MRC2 LY75	2.66e-05	14	80	3	PS00023
Domain	FN2	MRC1 MRC2 LY75	2.66e-05	14	80	3	SM00059
Domain	FN3	IL12RB2 COL6A3 CRLF1 DSCAM ABI3BP ROS1	1.43e-04	185	80	6	SM00060
Domain	YIPPEE	YPEL2 YPEL1	1.80e-04	5	80	2	PS51792
Domain	FN3	IL12RB2 COL6A3 CRLF1 DSCAM ABI3BP ROS1	2.12e-04	199	80	6	PS50853
Domain	Calcineurin-like_PHP_ApaH	PPP2CA PPP2CB PPP6C	2.29e-04	28	80	3	IPR004843
Domain	Metallophos	PPP2CA PPP2CB PPP6C	2.29e-04	28	80	3	PF00149
Domain	FN3_dom	IL12RB2 COL6A3 CRLF1 DSCAM ABI3BP ROS1	2.76e-04	209	80	6	IPR003961
Domain	Metallo-depent_PP-like	PPP2CA PPP2CB PPP6C	2.83e-04	30	80	3	IPR029052
Domain	-	PPP2CA PPP2CB PPP6C	2.83e-04	30	80	3	3.60.21.10
Domain	Kringle-like	MRC1 MRC2 LY75	3.43e-04	32	80	3	IPR013806
Domain	C_TYPE_LECTIN_1	ATRN MRC1 MRC2 LY75	3.86e-04	80	80	4	PS00615
Domain	Lectin_C	ATRN MRC1 MRC2 LY75	4.64e-04	84	80	4	PF00059
Domain	CLECT	ATRN MRC1 MRC2 LY75	4.64e-04	84	80	4	SM00034
Domain	C_TYPE_LECTIN_2	ATRN MRC1 MRC2 LY75	4.86e-04	85	80	4	PS50041
Domain	Yippee/Mis18/Cereblon	YPEL2 YPEL1	4.99e-04	8	80	2	IPR004910
Domain	Yippee-Mis18	YPEL2 YPEL1	4.99e-04	8	80	2	PF03226
Domain	C-type_lectin-like	ATRN MRC1 MRC2 LY75	5.08e-04	86	80	4	IPR001304
Domain	fn3	IL12RB2 CRLF1 DSCAM ABI3BP ROS1	6.57e-04	162	80	5	PF00041
Domain	C-type_lectin_CS	MRC1 MRC2 LY75	8.25e-04	43	80	3	IPR018378
Domain	C-type_lectin-like/link	ATRN MRC1 MRC2 LY75	8.63e-04	99	80	4	IPR016186
Domain	2OG-FeII_Oxy_3	EGLN3 EGLN1	9.72e-04	11	80	2	PF13640
Domain	6-blade_b-propeller_TolB-like	TECPR2 LRP1 ROS1	1.01e-03	46	80	3	IPR011042
Domain	CTDL_fold	ATRN MRC1 MRC2 LY75	1.15e-03	107	80	4	IPR016187
Domain	-	MRC1 MRC2	1.37e-03	13	80	2	2.10.10.10
Domain	WW_dom	WWOX GALNT9 IQGAP1	1.44e-03	52	80	3	IPR001202
Domain	TPR_8	NAA15 KDM6A CDC23	1.52e-03	53	80	3	PF13181
Domain	RasGAP	RASA1 IQGAP1	1.59e-03	14	80	2	SM00323
Domain	Dynein_heavy_chain_D4_dom	DNAH14 DNAH1	1.59e-03	14	80	2	IPR024317
Domain	Dynein_HC_stalk	DNAH14 DNAH1	1.59e-03	14	80	2	IPR024743
Domain	MT	DNAH14 DNAH1	1.59e-03	14	80	2	PF12777
Domain	AAA_8	DNAH14 DNAH1	1.59e-03	14	80	2	PF12780
Domain	RasGAP_CS	RASA1 IQGAP1	1.59e-03	14	80	2	IPR023152
Domain	LRR_6	NLRP9 CARMIL3 NLRP5	1.69e-03	55	80	3	PF13516
Domain	DHC_fam	DNAH14 DNAH1	1.83e-03	15	80	2	IPR026983
Domain	RasGAP	RASA1 IQGAP1	1.83e-03	15	80	2	PF00616
Domain	RAS_GTPASE_ACTIV_1	RASA1 IQGAP1	1.83e-03	15	80	2	PS00509
Domain	RAS_GTPASE_ACTIV_2	RASA1 IQGAP1	1.83e-03	15	80	2	PS50018
Domain	Dynein_heavy_dom	DNAH14 DNAH1	1.83e-03	15	80	2	IPR004273
Domain	Dynein_heavy	DNAH14 DNAH1	1.83e-03	15	80	2	PF03028
Domain	LY	LRP1 ROS1	1.83e-03	15	80	2	SM00135
Domain	LDLR_classB_rpt	LRP1 ROS1	1.83e-03	15	80	2	IPR000033
Domain	-	RASA1 IQGAP1	2.09e-03	16	80	2	1.10.506.10
Domain	P4Hc	EGLN3 EGLN1	2.09e-03	16	80	2	SM00702
Domain	Pro_4_hyd_alph	EGLN3 EGLN1	2.09e-03	16	80	2	IPR006620
Domain	RasGAP_dom	RASA1 IQGAP1	2.65e-03	18	80	2	IPR001936
Domain	2OG-FeII_Oxy	EGLN3 EGLN1	2.96e-03	19	80	2	PF03171
Domain	FE2OG_OXY	EGLN3 EGLN1	3.61e-03	21	80	2	PS51471
Domain	DAPIN	NLRP9 NLRP5	3.96e-03	22	80	2	PS50824
Domain	PYRIN	NLRP9 NLRP5	3.96e-03	22	80	2	PF02758
Domain	DAPIN	NLRP9 NLRP5	3.96e-03	22	80	2	IPR004020
Domain	PYRIN	NLRP9 NLRP5	3.96e-03	22	80	2	SM01289
Domain	NACHT	NLRP9 NLRP5	4.32e-03	23	80	2	PS50837
Domain	NACHT_NTPase	NLRP9 NLRP5	4.32e-03	23	80	2	IPR007111
Domain	Oxoglu/Fe-dep_dioxygenase	EGLN3 EGLN1	4.32e-03	23	80	2	IPR005123
Domain	MFS_1	SLC16A9 SLC16A14 SLC16A12	4.41e-03	77	80	3	PF07690
Domain	MFS	SLC16A9 SLC16A14 SLC16A12	4.41e-03	77	80	3	IPR011701
Domain	TPR_REGION	NAA15 TTC39C KDM6A CDC23	5.52e-03	165	80	4	PS50293
Domain	TPR	NAA15 TTC39C KDM6A CDC23	5.52e-03	165	80	4	PS50005
Domain	TPR_1	NAA15 KDM6A CDC23	6.80e-03	90	80	3	PF00515
Domain	TPR_1	NAA15 KDM6A CDC23	6.80e-03	90	80	3	IPR001440
Domain	PH	RASA1 FGD4 ELMO2 PLD2 TEC	6.84e-03	278	80	5	SM00233
Domain	PH_DOMAIN	RASA1 FGD4 ELMO2 PLD2 TEC	6.94e-03	279	80	5	PS50003
Domain	PH_domain	RASA1 FGD4 ELMO2 PLD2 TEC	7.04e-03	280	80	5	IPR001849
Domain	Glycos_transf_2	GALNT9 GALNT12	7.29e-03	30	80	2	PF00535
Domain	Glyco_trans_2-like	GALNT9 GALNT12	7.29e-03	30	80	2	IPR001173
Domain	-	IL12RB2 COL6A3 CRLF1 DSCAM ABI3BP ROS1 TREML2 IGSF3	7.41e-03	663	80	8	2.60.40.10
Domain	-	NLRP9 TNFRSF1A NLRP5	7.45e-03	93	80	3	1.10.533.10
Domain	-	ATRN MRC1 MRC2	8.36e-03	97	80	3	3.10.100.10
Pubmed	Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals.	LIMK1 ABCA1 ROS1	5.04e-08	4	82	3	18566305
Pubmed	Alpha 4 associates with protein phosphatases 2A, 4, and 6.	PPP2CA PPP2CB PPP6C	2.51e-07	6	82	3	9647778
Pubmed	Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation.	EGLN3 EGLN1 TNFRSF1A	7.01e-07	8	82	3	37400498
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATRN TUT4 WWOX SLC16A9 RASA1 TECPR2 SLC16A14 FBXO42 LRP1 KDM6A HNRNPA2B1 ALG12 DNAH14 DNAH1 XPO7	1.86e-06	1489	82	15	28611215
Pubmed	The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.	SLC16A9 SLC16A14 SLC16A12	4.51e-06	14	82	3	12739169
Pubmed	Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A.	PPP2CA PPP2CB	5.49e-06	2	82	2	2555176
Pubmed	Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.	EGLN3 EGLN1	5.49e-06	2	82	2	38400673
Pubmed	Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1.	MRC1 MRC2	5.49e-06	2	82	2	19224860
Pubmed	Single molecule recognition between cytochrome C 551 and gold-immobilized azurin by force spectroscopy.	LIMK1 ABCA1	5.49e-06	2	82	2	16192283
Pubmed	Mannose receptor regulation of macrophage cell migration.	MRC1 MRC2	5.49e-06	2	82	2	17596337
Pubmed	Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway.	ABCA1 PLD2	5.49e-06	2	82	2	16118212
Pubmed	The role of protein phosphatase 2A catalytic subunit Calpha in embryogenesis: evidence from sequence analysis and localization studies.	PPP2CA PPP2CB	5.49e-06	2	82	2	10543450
Pubmed	HIV-1 Tat represses transcription from the mannose receptor promoter.	MRC1 MRC2	5.49e-06	2	82	2	11120831
Pubmed	SM-20 is a novel growth factor-responsive gene regulated during skeletal muscle development and differentiation.	EGLN3 EGLN1	5.49e-06	2	82	2	10543731
Pubmed	Depletion of Endothelial Prolyl Hydroxylase Domain Protein 2 and 3 Promotes Cardiomyocyte Proliferation and Prevents Ventricular Failure Induced by Myocardial Infarction.	EGLN3 EGLN1	5.49e-06	2	82	2	31356139
Pubmed	IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis.	IL12RB2 ABCA1	5.49e-06	2	82	2	18927311
Pubmed	Regulation of spindle formation by active mitogen-activated protein kinase and protein phosphatase 2A during mouse oocyte meiosis.	PPP2CA PPP2CB	5.49e-06	2	82	2	11751260
Pubmed	Association of human mannose receptor in sexual transmission of human immunodeficiency virus in serodiscordant couples.	MRC1 MRC2	5.49e-06	2	82	2	23148569
Pubmed	The mannose receptor on murine liver sinusoidal endothelial cells is the main denatured collagen clearance receptor.	MRC1 MRC2	5.49e-06	2	82	2	17518370
Pubmed	CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor.	MRC1 MRC2	5.49e-06	2	82	2	15047828
Pubmed	Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities.	PPP2CA PPP2CB	5.49e-06	2	82	2	34902541
Pubmed	Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes.	PPP2CA PPP2CB	5.49e-06	2	82	2	2837763
Pubmed	The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia.	EGLN3 EGLN1	5.49e-06	2	82	2	19737309
Pubmed	Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes.	PPP2CA PPP2CB	5.49e-06	2	82	2	1846293
Pubmed	Tumor necrosis factor-alpha and lymphotoxin-alpha increase macrophage ABCA1 by gene expression and protein stabilization via different receptors.	ABCA1 TNFRSF1A	5.49e-06	2	82	2	19913791
Pubmed	PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte.	PPP2CA PPP2CB	5.49e-06	2	82	2	27096707
Pubmed	Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor.	MRC1 MRC2	5.49e-06	2	82	2	17360361
Pubmed	Overexpression of GLP-1 receptors suppresses proliferation and cytokine release by airway smooth muscle cells of patients with chronic obstructive pulmonary disease via activation of ABCA1.	ABCA1 GLP1R	5.49e-06	2	82	2	28560433
Pubmed	Protein phosphatase 2A family members (PP2A and PP6) associate with U1 snRNP and the spliceosome during pre-mRNA splicing.	PPP2CA PPP6C	5.49e-06	2	82	2	24064353
Pubmed	Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart.	PPP2CA PPP2CB	5.49e-06	2	82	2	11113010
Pubmed	A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity.	PPP2CA PPP2CB PPP6C	1.00e-05	18	82	3	16085932
Pubmed	Molecular oxygen sensing: implications for visceral surgery.	EGLN3 EGLN1	1.64e-05	3	82	2	22395314
Pubmed	HIV-1 interaction with human mannose receptor (hMR) induces production of matrix metalloproteinase 2 (MMP-2) through hMR-mediated intracellular signaling in astrocytes.	MRC1 MRC2	1.64e-05	3	82	2	15955449
Pubmed	Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2.	EGLN3 EGLN1	1.64e-05	3	82	2	23690557
Pubmed	Systemic hypoxia mimicry enhances axonal regeneration and functional recovery following peripheral nerve injury.	EGLN3 EGLN1	1.64e-05	3	82	2	32814068
Pubmed	The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer.	EGLN3 EGLN1	1.64e-05	3	82	2	36509284
Pubmed	Characterization and comparative analysis of the EGLN gene family.	EGLN3 EGLN1	1.64e-05	3	82	2	11574160
Pubmed	Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases.	EGLN3 EGLN1	1.64e-05	3	82	2	27561929
Pubmed	Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury.	EGLN3 EGLN1	1.64e-05	3	82	2	22262480
Pubmed	Loss of Prolyl-Hydroxylase 1 Protects against Biliary Fibrosis via Attenuated Activation of Hepatic Stellate Cells.	EGLN3 EGLN1	1.64e-05	3	82	2	30248340
Pubmed	Molecular characterization of the orphan transporter SLC16A9, an extracellular pH- and Na+-sensitive creatine transporter.	SLC16A9 SLC16A12	1.64e-05	3	82	2	31784090
Pubmed	In silico identification and structural features of six new genes similar to MATER specifically expressed in the oocyte.	NLRP9 NLRP5	1.64e-05	3	82	2	15474461
Pubmed	Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.	EGLN3 EGLN1	1.64e-05	3	82	2	21887331
Pubmed	Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins.	MRC1 MRC2	1.64e-05	3	82	2	30366943
Pubmed	Hematological, hepatic, and retinal phenotypes in mice deficient for prolyl hydroxylase domain proteins in the liver.	EGLN3 EGLN1	1.64e-05	3	82	2	24508125
Pubmed	Distribution of murine mannose receptor expression from early embryogenesis through to adulthood.	MRC1 MRC2	1.64e-05	3	82	2	9560474
Pubmed	The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo.	PPP2CA PPP2CB	1.64e-05	3	82	2	8206937
Pubmed	Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases.	EGLN3 EGLN1	1.64e-05	3	82	2	27502280
Pubmed	Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis.	EGLN3 EGLN1	1.64e-05	3	82	2	27981571
Pubmed	Association of rs1466535 LRP1 but not rs3019885 SLC30A8 and rs6674171 TDRD10 gene polymorphisms with abdominal aortic aneurysm in Italian patients.	SLC30A8 LRP1	1.64e-05	3	82	2	24423473
Pubmed	Analysis of HIF-prolyl hydroxylases binding to substrates.	EGLN3 EGLN1	1.64e-05	3	82	2	17069766
Pubmed	Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation.	EGLN3 EGLN1	1.64e-05	3	82	2	22343896
Pubmed	Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.	EGLN3 EGLN1	1.64e-05	3	82	2	24195777
Pubmed	Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility.	EGLN3 EGLN1	1.64e-05	3	82	2	20959442
Pubmed	Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts.	PPP2CA PPP2CB	1.64e-05	3	82	2	7510677
Pubmed	Mammalian EGLN genes have distinct patterns of mRNA expression and regulation.	EGLN3 EGLN1	1.64e-05	3	82	2	12234095
Pubmed	Role of the intracellular localization of HIF-prolyl hydroxylases.	EGLN3 EGLN1	1.64e-05	3	82	2	19339211
Pubmed	Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism.	EGLN3 EGLN1	1.64e-05	3	82	2	26774962
Pubmed	Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.	EGLN3 EGLN1	1.64e-05	3	82	2	24037093
Pubmed	C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.	EGLN3 EGLN1	1.64e-05	3	82	2	11595184
Pubmed	HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus.	EGLN3 EGLN1	1.64e-05	3	82	2	11595178
Pubmed	Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.	EGLN3 EGLN1	1.64e-05	3	82	2	21877141
Pubmed	The alpha4 regulatory subunit exerts opposing allosteric effects on protein phosphatases PP6 and PP2A.	PPP2CA PPP6C	1.64e-05	3	82	2	16895907
Pubmed	Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates.	EGLN3 EGLN1	1.64e-05	3	82	2	31500697
Pubmed	Expression of HIF prolyl hydroxylase isozymes in growth plate chondrocytes: relationship between maturation and apoptotic sensitivity.	EGLN3 EGLN1	1.64e-05	3	82	2	17044072
Pubmed	Naturally Occurring Variants in LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Affect HDL (High-Density Lipoprotein) Metabolism Through ABCA1 (ATP-Binding Cassette A1) and SR-B1 (Scavenger Receptor Class B Type 1) in Humans.	ABCA1 LRP1	1.64e-05	3	82	2	29853565
Pubmed	HIV gp120 binds to mannose receptor on vaginal epithelial cells and induces production of matrix metalloproteinases.	MRC1 MRC2	1.64e-05	3	82	2	22132194
Pubmed	Improved vascular survival and growth in the mouse model of hindlimb ischemia by a remote signaling mechanism.	EGLN3 EGLN1	1.64e-05	3	82	2	24440788
Pubmed	Hypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2.	EGLN3 EGLN1	1.64e-05	3	82	2	28418093
Pubmed	PHD2/3-dependent hydroxylation tunes cardiac response to β-adrenergic stress via phospholamban.	EGLN3 EGLN1	1.64e-05	3	82	2	26075818
Pubmed	Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis.	EGLN3 EGLN1	1.64e-05	3	82	2	22786772
Pubmed	Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing.	EGLN3 EGLN1	1.64e-05	3	82	2	12615973
Pubmed	Opposing regulation and roles for PHD3 in lung dendritic cells and alveolar macrophages.	EGLN3 EGLN1	1.64e-05	3	82	2	28716863
Pubmed	Kinetic rationale for selectivity toward N- and C-terminal oxygen-dependent degradation domain substrates mediated by a loop region of hypoxia-inducible factor prolyl hydroxylases.	EGLN3 EGLN1	1.64e-05	3	82	2	18063574
Pubmed	Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice.	EGLN3 EGLN1	1.64e-05	3	82	2	22615432
Pubmed	Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favors association with the alpha 4 subunit which promotes dephosphorylation of elongation factor-2.	PPP2CA PPP2CB	1.64e-05	3	82	2	10441131
Pubmed	Hypoxia-inducible factor prolyl hydroxylase domain (PHD) inhibition after contusive spinal cord injury does not improve locomotor recovery.	EGLN3 EGLN1	1.64e-05	3	82	2	33819286
Pubmed	Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function.	PPP2CA PPP2CB	1.64e-05	3	82	2	23341017
Pubmed	Localization of the genes encoding the catalytic subunits of protein phosphatase 2A to human chromosome bands 5q23-->q31 and 8p12-->p11.2, respectively.	PPP2CA PPP2CB	1.64e-05	3	82	2	8383590
Pubmed	Prolyl hydroxylase domain proteins regulate bone mass through their expression in osteoblasts.	EGLN3 EGLN1	1.64e-05	3	82	2	27614241
Pubmed	Overlapping binding sites in protein phosphatase 2A for association with regulatory A and alpha-4 (mTap42) subunits.	PPP2CA PPP2CB	1.64e-05	3	82	2	15252037
Pubmed	HIF prolyl hydroxylase 2/3 deletion disrupts astrocytic integrity and exacerbates neuroinflammation.	EGLN3 EGLN1	1.64e-05	3	82	2	37140003
Pubmed	Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function.	EGLN3 EGLN1	1.64e-05	3	82	2	20600011
Pubmed	The expression of prolyl hydroxylase domain enzymes are up-regulated and negatively correlated with Bcl-2 in non-small cell lung cancer.	EGLN3 EGLN1	3.28e-05	4	82	2	21748337
Pubmed	Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.	EGLN3 EGLN1	3.28e-05	4	82	2	20028863
Pubmed	HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.	EGLN3 EGLN1	3.28e-05	4	82	2	23264599
Pubmed	Involvement of Nlrp9a/b/c in mouse preimplantation development.	NLRP9 NLRP5	3.28e-05	4	82	2	32413845
Pubmed	Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins.	EGLN3 EGLN1	3.28e-05	4	82	2	18056838
Pubmed	Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.	PPP2CA PPP2CB	3.28e-05	4	82	2	11371618
Pubmed	A conserved family of prolyl-4-hydroxylases that modify HIF.	EGLN3 EGLN1	3.28e-05	4	82	2	11598268
Pubmed	The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation.	PPP2CA PPP2CB	3.28e-05	4	82	2	21454489
Pubmed	Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis.	EGLN3 EGLN1	3.28e-05	4	82	2	22955912
Pubmed	Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system.	EGLN3 EGLN1	3.28e-05	4	82	2	17646578
Pubmed	M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway.	MRC1 MRC2	3.28e-05	4	82	2	24019537
Pubmed	Direct stimulation of receptor-controlled phospholipase D1 by phospho-cofilin.	LIMK1 PLD2	3.28e-05	4	82	2	17853892
Pubmed	A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis.	ABCA1 GLP1R	3.28e-05	4	82	2	24493833
Pubmed	Regulation of IL-1β-induced NF-κB by hydroxylases links key hypoxic and inflammatory signaling pathways.	EGLN3 EGLN1	3.28e-05	4	82	2	24145445
Pubmed	The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic.	PPP2CA PPP2CB	3.28e-05	4	82	2	14633983
Pubmed	Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors.	EGLN3 EGLN1	3.28e-05	4	82	2	12163023
Pubmed	Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor.	EGLN3 EGLN1	3.28e-05	4	82	2	12788921
GeneFamily	Protein phosphatase catalytic subunits\|EF-hand domain containing	PPP2CA PPP2CB PPP6C	1.29e-05	13	66	3	693
GeneFamily	Yippee like family	YPEL2 YPEL1	1.30e-04	5	66	2	1130
GeneFamily	Fibronectin type III domain containing	IL12RB2 CRLF1 DSCAM ABI3BP ROS1	2.95e-04	160	66	5	555
GeneFamily	C-type lectin domain family	MRC1 MRC2 LY75	6.72e-04	47	66	3	494
GeneFamily	Dyneins, axonemal	DNAH14 DNAH1	1.72e-03	17	66	2	536
GeneFamily	Protein phosphatase catalytic subunits\|STRIPAK complex	PPP2CA PPP2CB	2.39e-03	20	66	2	1371
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT9 GALNT12	2.39e-03	20	66	2	433
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	MRC1 MRC2 LRP1 ADGRE5 TNFRSF1A LY75	3.11e-03	394	66	6	471
GeneFamily	NLR family	NLRP9 NLRP5	3.73e-03	25	66	2	666
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	NLRP9 NLRP5	3.73e-03	25	66	2	994
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	MRC1 LY75	4.34e-03	27	66	2	1253
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TTC39C KDM6A CDC23	8.58e-03	115	66	3	769
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CRLF1 DSCAM MRC2 SLC30A8 LRP1 IGSF3	4.65e-08	182	82	7	f4b74c2756989812abe4e7055ec8918f69d56025
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CRLF1 DSCAM MRC2 SLC30A8 LRP1 IGSF3	5.39e-08	186	82	7	35c88cc4eb388811fcac4323b549e5897fa8dc27
ToppCell	droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CRLF1 DSCAM MRC2 SLC30A8 LRP1 IGSF3	5.39e-08	186	82	7	d998c5b00083cf2a7cd5341a98b7374b4de73c63
ToppCell	facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK3 COL6A3 DSCAM PLD2 SUCNR1 IGSF3	5.75e-07	163	82	6	b83a35c4426d66b5734a98fa6c72b345fe462030
ToppCell	facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK3 COL6A3 DSCAM PLD2 SUCNR1 IGSF3	5.75e-07	163	82	6	c20ca9b6b4170ebcb0e66eef3e5d8ebff22b1a91
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CRLF1 ABI3BP MRC2 LRP1 IGSF3	1.54e-06	193	82	6	eff718664fe0aaf89050efd9cc7b6dfb1df46666
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	COL6A3 WWOX ABI3BP MRC2 LRP1 CATSPERB	1.59e-06	194	82	6	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 ABCA1 ABI3BP MRC2 LRP1 MSTN	1.73e-06	197	82	6	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MRC1 ABCA1 LRP1 ADGRE5 GPRC5A ADCY7	1.84e-06	199	82	6	155b03b859157013e9142e9248551369127d9204
ToppCell	RV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	COL6A3 ABI3BP EFCAB12 PRPH2 CATSPERB	4.94e-06	134	82	5	8c4046ba1f85172915a112499e492c3efe8474c2
ToppCell	10x5'-Liver-Myeloid_Mac-Intestinal_macrophages\|Liver / Manually curated celltypes from each tissue	MRC1 ABCA1 SLC16A9 MRC2 SUCNR1	1.03e-05	156	82	5	9a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 UBE2O CRLF1 TECPR2 LRP1	1.17e-05	160	82	5	56e6f4b82b5dc41c45f9d253c2db314a6f702b84
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 UBE2O CRLF1 TECPR2 LRP1	1.17e-05	160	82	5	bb1b966fb9e801db15e67d03e49db4609d6f935a
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IL12RB2 TTC39C TEC UBASH3B ADCY7	1.95e-05	178	82	5	7905621f5b2aa55324c5592d1d2fef763a5fa41f
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IL12RB2 TTC39C TEC UBASH3B ADCY7	1.95e-05	178	82	5	f914092c20130207193f97c6044ae61a9a440a86
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	COL6A3 CRLF1 ABI3BP MRC2 CATSPERB	2.01e-05	179	82	5	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	RA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL6A3 ABI3BP MRC2 CATSPERB GPRC5A	2.12e-05	181	82	5	2b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK3 WWOX ABI3BP TTC39C KDM6A	2.29e-05	184	82	5	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL6A3 CRLF1 ABI3BP MRC2 LRP1	2.35e-05	185	82	5	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 COL6A3 ABI3BP LRP1 UBASH3B	2.35e-05	185	82	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	facs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL6B ABI3BP MRC2 LRP1 GPRC5A	2.67e-05	190	82	5	990ac07f4b0a22041daac7502f74fafd6d258cba
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL6A3 EGLN3 ABI3BP CATSPERB ERI2	2.67e-05	190	82	5	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	facs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL6B ABI3BP MRC2 LRP1 GPRC5A	2.67e-05	190	82	5	fc9bbe5e6e0ec3cfa47bf479d8b09a0fc53169cc
ToppCell	facs-Thymus-Flowthrough-24m-Mesenchymal\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCL6B ABI3BP MRC2 LRP1 GPRC5A	2.67e-05	190	82	5	39ecdf8815e235771132684dfc1aff1917e20965
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 IL12RB2 ABCA1 LRP1 ADCY7	2.74e-05	191	82	5	51f5af610983aa73b9f4ece6f27d281ebff89a04
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 IL12RB2 ABCA1 LRP1 ADCY7	2.74e-05	191	82	5	8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5
ToppCell	facs-Aorta-Heart-18m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ABI3BP MRC2 LRP1 IGSF3	2.74e-05	191	82	5	6242f83acaf1714e9c1771a832cb67674b19e96d
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL6A3 EGLN3 ABI3BP MRC2 CATSPERB	2.74e-05	191	82	5	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	droplet-Kidney-nan-18m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CRLF1 ABI3BP MRC2 LRP1	2.81e-05	192	82	5	38d7a24ae205ef91ed2e0f402d8022f2a9cdb243
ToppCell	facs-Aorta-Heart-18m-Mesenchymal\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ABI3BP MRC2 LRP1 IGSF3	2.81e-05	192	82	5	6d4fe7ea278efa4b9d43f8a3c282bc0e0e9abaea
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ABI3BP MRC2 LRP1 GNRHR	2.81e-05	192	82	5	853a930e0641ffb50cbb4cef5837c70d75c3fc39
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CRLF1 ABI3BP MRC2 LRP1	2.81e-05	192	82	5	04d155897ed075c359933080e36a4ab2150b6e9f
ToppCell	facs-Aorta-Heart-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ABI3BP MRC2 LRP1 IGSF3	2.81e-05	192	82	5	2c6406bc97c3224099b94a43f2890f057b528fa6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRE5 TNFRSF1A GPRC5A UBASH3B IQGAP1	2.81e-05	192	82	5	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ABI3BP MRC2 LRP1 GNRHR	2.81e-05	192	82	5	d2c03490c5e835d0f0a732803093c64b8d4b4029
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	COL6A3 ABI3BP MRC2 LRP1 SLC16A12	2.81e-05	192	82	5	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CRLF1 ABI3BP MRC2 LRP1	2.81e-05	192	82	5	84149a5c6c3b3c9b86aed77cf8e72d99ef099fab
ToppCell	facs-Aorta-Heart-18m-Mesenchymal-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ABI3BP MRC2 LRP1 IGSF3	2.81e-05	192	82	5	47aed7c8e6f5ce1084821212a04f568319e65fd6
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ABI3BP MRC2 LRP1 GNRHR	2.81e-05	192	82	5	49281626ecad0456fdbded2378b7028d7b589686
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA1 WWOX RASA1 FGD4 KDM6A	2.88e-05	193	82	5	779276e775cb2492e8dd36436295a536084a6415
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	COL6A3 CRLF1 ABI3BP MRC2 CATSPERB	2.95e-05	194	82	5	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL6A3 CRLF1 ABI3BP LRP1 GPRC5A	2.95e-05	194	82	5	69362e13158033de44f90f3773db6c0f27de8cb3
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	COL6A3 CRLF1 ABI3BP MRC2 LRP1	2.95e-05	194	82	5	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 ABI3BP MRC2 LRP1 SLC16A12	2.95e-05	194	82	5	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MRC1 IL12RB2 ABCA1 LRP1 ADCY7	2.95e-05	194	82	5	1dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	MRC1 ABCA1 LRP1 UBASH3B ADCY7	3.02e-05	195	82	5	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL6A3 WWOX ABI3BP MRC2 CATSPERB	3.02e-05	195	82	5	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	COL6A3 ABI3BP MRC2 LRP1 CATSPERB	3.02e-05	195	82	5	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 ABI3BP MRC2 LRP1 MSTN	3.10e-05	196	82	5	fcb275746bf51269ed8ba4cf93edb054a45f1ccd
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 ABCA1 ABI3BP LRP1 CRYBG3	3.10e-05	196	82	5	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MRC1 ABCA1 LRP1 UBASH3B ADCY7	3.10e-05	196	82	5	7026c1fc33425e5476063d17c79e4b79356a9e01
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL6A3 ABI3BP MRC2 CATSPERB GPRC5A	3.10e-05	196	82	5	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 CRLF1 ABI3BP MRC2 LRP1	3.18e-05	197	82	5	71786e9432e2d649f5d86f639abb25e7102deb67
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ABCA1 ABI3BP FXYD4 ITLN2 GPRC5A	3.18e-05	197	82	5	69d5b8588046d119b5dff9a7fd6f49e97e00a5b7
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ABCA1 ABI3BP FXYD4 ITLN2 GPRC5A	3.18e-05	197	82	5	e6cbfa267eb2e05b441fd034786faae07bb0e081
ToppCell	Biopsy_IPF-Epithelial-AT1\|Biopsy_IPF / Sample group, Lineage and Cell type	ABI3BP MRC2 FXYD4 ITLN2 GPRC5A	3.25e-05	198	82	5	75bdecbe111fededf6082b11de18b84ca308ef6d
ToppCell	distal-mesenchymal-Adventitial_Fibroblast-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A3 ABI3BP MRC2 PRPH2 SLC16A12	3.25e-05	198	82	5	bfd720e2dae3b6b3dc2bf8b2096c554fd456e756
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A3 ABCA1 ABI3BP MRC2 LRP1	3.33e-05	199	82	5	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	368C-Fibroblasts-Fibroblast-D-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 ABI3BP LRP1 TNFRSF1A GPRC5A	3.33e-05	199	82	5	8766796041965a1ba40ad7abdbc244bf1418c209
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A3 ABCA1 ABI3BP MRC2 LRP1	3.33e-05	199	82	5	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 CRLF1 ABI3BP MRC2 LRP1	3.33e-05	199	82	5	9672230aa0bc6a7289050c955f5154ca183a5159
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A3 ABCA1 ABI3BP MRC2 LRP1	3.33e-05	199	82	5	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 CRLF1 ABI3BP MRC2 LRP1	3.33e-05	199	82	5	e18abe678da293bd01fae55e2f9ab6fdd643d02d
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A3 ABCA1 ABI3BP MRC2 LRP1	3.33e-05	199	82	5	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A3 ABCA1 ABI3BP MRC2 LRP1	3.33e-05	199	82	5	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	distal-2-mesenchymal-Adventitial_Fibroblast\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	COL6A3 ABI3BP MRC2 PRPH2 SLC16A12	3.33e-05	199	82	5	97b475f9110ef7bb29d9cf2109b7e43177830f05
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 CRLF1 ABI3BP MRC2 LRP1	3.33e-05	199	82	5	1fd7bbb8727607e6507848602a19bc86882ef2d5
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL6A3 ABCA1 ABI3BP MRC2 LRP1	3.33e-05	199	82	5	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A3 ABCA1 ABI3BP MRC2 LRP1	3.33e-05	199	82	5	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	368C-Fibroblasts-Fibroblast-D\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL6A3 ABI3BP LRP1 TNFRSF1A GPRC5A	3.33e-05	199	82	5	d39b40d84c72bdde756b805063317ecfad3784f8
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 CRLF1 ABI3BP MRC2 LRP1	3.41e-05	200	82	5	17ffdbc13332bd3ed1d54abcd7af20267dd4b234
ToppCell	mLN-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	MRC1 FGD4 LRP1 TNFRSF1A IQGAP1	3.41e-05	200	82	5	e3c15e0e1c2602b0cc9ab8cc50c978d265350c94
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 CRLF1 ABI3BP MRC2 LRP1	3.41e-05	200	82	5	665df8391d2ebcfc6536318612f4992852b5e2b8
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 CRLF1 ABI3BP MRC2 LRP1	3.41e-05	200	82	5	44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f
ToppCell	Biopsy_IPF-Epithelial-KRT5-/KRT17+\|Biopsy_IPF / Sample group, Lineage and Cell type	DOCK3 CRLF1 ROS1 GPRC5A IGSF3	3.41e-05	200	82	5	2fc7a3b3aea711ad3d96fd9513f4b40533056d86
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A3 ABCA1 ABI3BP MRC2 LRP1	3.41e-05	200	82	5	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	cellseq2-Mesenchymal-Fibroblastic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 CRLF1 ABI3BP MRC2 LRP1	3.41e-05	200	82	5	1c10597edd532bf172ca09870a937d35e2585081
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 ABCA1 ABI3BP MRC2 LRP1	3.41e-05	200	82	5	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 ABCA1 ABI3BP MRC2 LRP1	3.41e-05	200	82	5	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 CRLF1 ABI3BP MRC2 LRP1	3.41e-05	200	82	5	440dda48b09c6a8581b7ca634b0d67f1ecacf65e
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GALNT12 ACSBG2 TTPA NLRP5	8.93e-05	127	82	4	5b0adbcafad31a6759c9bdce2f7f9591a8edc450
ToppCell	droplet-Tongue-Unstain-18m-Epithelial-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FGD4 GPRC5A UBASH3B MAP3K6	1.07e-04	133	82	4	f7d0763b5eec2db33044d6850fd57462494038c1
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_TIP\|Cerebellum / BrainAtlas - Mouse McCarroll V32	COL6A3 MRC2 GALNT12 GPRC5A	1.65e-04	149	82	4	3980fa4f1986a2f164a1826ea043fb71f1d756cd
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TAF1A PLD2 CRYBG3 ALG12	1.70e-04	150	82	4	6f7087a051a2f05c5611ff65a945c01736d5ec2b
ToppCell	390C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MRC2 TAF1A TEC DNAH1	1.78e-04	152	82	4	ebce79e106bf1d84241f8dd3496ff1771f9666be
ToppCell	390C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MRC2 TAF1A TEC DNAH1	1.78e-04	152	82	4	4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	COL6A3 MRC2 GALNT12 SLC16A12	1.88e-04	154	82	4	65dbb60f636562eeba3dafadae9c0c7db2b27476
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC16A9 TTC39C FBXO42 TNFRSF1A	1.97e-04	156	82	4	895927228c93cd090303984c5be6ebfb59ed6f3a
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC16A9 PLD2 ADCY7 IQGAP1	2.02e-04	157	82	4	ec433d2fe827abdb647be4176c231b7052482b6f
ToppCell	facs-Marrow-B-cells-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 CARMIL3 LRP1 GNRHR	2.02e-04	157	82	4	0966e347f8d32b13f8a3b3afba3f64637c69cdf9
ToppCell	facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 CARMIL3 LRP1 GNRHR	2.02e-04	157	82	4	6ebfedd91d62c6d4aa8f046657a899a279f82ba2
ToppCell	facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 TTC39C GALNT9 IQGAP1	2.17e-04	160	82	4	1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 ABCA1 UBE2O LRP1	2.17e-04	160	82	4	0544bc465af208da448858d6e174ff56f2e08a46
ToppCell	PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UBE2O TEC UBASH3B TREML2	2.22e-04	161	82	4	52556b89808e551540f33a13f57417a6696c2438
ToppCell	PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UBE2O TEC UBASH3B TREML2	2.22e-04	161	82	4	54f156cf2bd5a6ba9a78ec4e3ee28b89998aec2e
ToppCell	facs-Spleen-nan-3m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 FGD4 LRP1 SUCNR1	2.22e-04	161	82	4	45591addc765760db6029ac19e80573373d1d917
ToppCell	facs-Spleen-nan-3m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 FGD4 LRP1 SUCNR1	2.22e-04	161	82	4	8741b91a62c9a8ce377ef6533d323b65beb93c63
ToppCell	PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UBE2O TEC UBASH3B TREML2	2.22e-04	161	82	4	242891be849a4398fe8bea44875ae1ba57950944
ToppCell	facs-Spleen-nan-3m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 FGD4 LRP1 SUCNR1	2.22e-04	161	82	4	9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 UBE2O CRLF1 LRP1	2.22e-04	161	82	4	60f433eab9d5531bdf6aa86b0265f20b866b904c
Drug	dimethyloxalylglycine; Up 200; 1000uM; PC3; HG-U133A	UBE2O GLP1R FBXO42 EGLN1 LRP1 GPRC5A YPEL1	2.48e-06	172	80	7	584_UP
Drug	Tiletamine hydrochloride; Up 200; 15.4uM; HL60; HT_HG-U133A	DSCAM ABI3BP LRP1 PRPH2 PLD2 YPEL1 ALG12	6.49e-06	199	80	7	3137_UP
Drug	GA 7	EGLN3 NAA15 EGLN1	1.16e-05	13	80	3	CID000092782
Disease	tyrosine-protein kinase TEC measurement	TEC TEC	4.12e-05	4	78	2	EFO_0020830
Disease	myocardial infarction (biomarker_via_orthology)	EGLN3 EGLN1 TNFRSF1A KDM6A	8.69e-04	160	78	4	DOID:5844 (biomarker_via_orthology)
Disease	sphingosine 1-phosphate measurement	UBE2O KDM6A	1.03e-03	18	78	2	EFO_0800185
Disease	cystathionine measurement	TEC TEC	1.15e-03	19	78	2	EFO_0010474
Disease	reasoning	EGLN3 WWOX	1.15e-03	19	78	2	EFO_0004350
Disease	myeloperoxidase (MPO)-DNA complex measurement	YPEL2 CATSPERB	1.54e-03	22	78	2	EFO_0011039
Disease	Pigmented Basal Cell Carcinoma	PPP6C RASA1	2.49e-03	28	78	2	C1368275

Protein segments in the cluster

Peptide	Gene	Start	Entry
KKWEILNFNQYYEAC	ACSBG2	76	Q5FVE4
KYQENRKCCGYFKWE	ERI2	626	A8K979
KVLECHWEKYNNRYT	EDDM3A	101	Q14507
LNQLVEAKKCYWRAY	CDC23	446	Q9UJX2
LAQYYFKCKLWDEAS	CDC23	516	Q9UJX2
YVKGKLWYNERCFAN	CATSPERB	291	Q9H7T0
QIWYYCRGLFKSKAS	CRYBG3	2876	Q68DQ2
GLKIKSLNWYEDNNY	ABCA1	316	O95477
EYRKWACLVAGGSKY	ADGRE5	796	P48960
QIDYYCRLDCLWKKK	ADCY7	816	P51828
NFLVYLQCWKLCKSY	EFCAB12	391	Q6NXP0
ITCIYYLNKNWDAKL	EGLN3	146	Q9H6Z9
RGCSYLLNNYKKSWL	ALG12	326	Q9BV10
CIQSQWRGYKQKKAY	IQGAP1	781	P46940
KYYRLCDKAEAWGIV	GPRC5A	16	Q8NFJ5
RYIYGCLQKSVQHKW	RASA1	871	P20936
KQWYRLIKGVAHQCY	FBXO42	76	Q6P3S6
TYFCKQLAKRKWQLY	SLC16A9	276	Q7RTY1
QLAKRKWQLYKNYCG	SLC16A9	281	Q7RTY1
KWQLYKNYCGETVAL	SLC16A9	286	Q7RTY1
SLNYWCNLLGMKIYE	GLOD4	166	Q9HC38
IVKYLYEDEGCWTRN	GLP1R	286	P43220
QEICNRYDKKYSWDV	PUDP	31	Q08623
KCRSFKWYLENVYPE	GALNT9	441	Q9HCQ5
YQDGKLYWCDARTDK	LRP1	2061	Q07954
EEKYKTFNKYWCRQP	CD300H	46	A0A0K2S4Q6
NYKYKTKCTWLIEGQ	ATRN	151	O75882
NLTWQKQCKDIYCDY	IL12RB2	166	Q99665
ACQYKLAVERYEWNK	KDM6A	1246	O15550
LAYNQWFTKLYCKDL	CARMIL3	211	Q8ND23
LARKGCVEKMQYYWD	MAP3K6	426	O95382
GYVVCWKCSDYKAQL	FGD4	586	Q96M96
TTLNYEYDRKWGICL	LY75	196	O60449
QGWASDTKLRYCYKV	MRC2	671	Q9UBG0
SSYGLQWCLYELDKE	NLRP5	61	P59047
DECLRKYGNANVWKY	PPP2CB	131	P62714
DECLRKYGNANVWKY	PPP2CA	131	P67775
YDEAIKCYRNALKWD	NAA15	96	Q9BXJ9
QKLKYKWCEVGVLDY	DNAH1	296	Q9P2D7
GSWDKCKFYVNKYLV	EFCAB5	1401	A4FU69
GKYQCVAELWRKNYN	IGSF3	641	O75054
ACNWKKYKYIVLNSQ	BCL6B	191	Q8N143
GALAYKELIRCLKWY	DOCK3	696	Q8IZD9
QWYAGELLCKVLSYL	GNRHR	106	P30968
NKYEYCIWIDGLSAL	ELMO2	651	Q96JJ3
CIYSKNEKWLSIAYG	CLPSL1	91	A2RUU4
CRDFILKWYYDPNTK	COL6A3	3121	P12111
LKWYYDPNTKSCARF	COL6A3	3126	P12111
WNPLCKEKKYDYDNL	GALNT12	121	Q8IXK2
YKWNEKQKLCYVSQG	DNAH14	1106	Q0VDD8
CIYYLNKDWDAKVSG	EGLN1	326	Q9GZT9
KYPVKYRSGKCWNDN	ITLN2	201	Q8WWU7
WNLYGKCRYRCSKKE	DEFB123	26	Q8N688
LKYKLRWYGQDNTCE	CRLF1	171	O75462
LKSACVYLDLDGYWK	MRC1	1186	P22897
YRLENLKCGTWYKFT	DSCAM	1436	O60469
YYDWKNLQLSGLICG	FXYD4	31	P59646
CSYKGYKNRVEGKVW	TREML2	41	Q5T2D2
GKKSNNLDQYEWYCR	TEC	236	P42680
TVLLKYLCAEYGWRN	SLC16A14	176	Q7RTX9
FGWLTDRRCLKNYQY	SLC16A12	336	Q6ZSM3
GCTKNITAWKYLAKY	TAF1A	341	Q15573
DWIIAPKRYKANYCS	MSTN	296	O14793
NYRKCRIKLSGYAWV	CCNB1IP1	11	Q9NPC3
SGCISDYNEKLVYWR	NLRP9	606	Q7RTR0
DIYCENCKTTLGWKY	YPEL1	76	O60688
EKGANEYAYAKWKLC	SLC30A8	61	Q8IWU4
SLRNYYEQWGKLTDC	HNRNPA2B1	36	P22626
TKYGNANAWRYCTKV	PPP6C	131	O00743
ICYDALDPAKYARWK	PRPH2	81	P23942
YDCWLGKVYDLKNQI	UBE2O	206	Q9C0C9
DYWAMLAYNRSKLCN	WWOX	286	Q9NZC7
WEKAEDNGCRITYYI	ROS1	1771	P08922
LVVSEKYIWCLDYKG	TECPR2	816	O15040
KNYYKWRAECPEISA	TTPA	71	P49638
CKNWLAAEAALEKYY	SUCNR1	11	Q9BXA5
DIYCENCKTTLGWKY	YPEL2	76	Q96QA6
LYARITKLGWFDCQK	XPO7	111	Q9UIA9
KYWLSQCFDAKGRYI	UBASH3B	401	Q8TF42
WKIYNKCYLDINALQ	TTC39C	166	Q8N584
SYSECKGKQYVKRTW	ABI3BP	951	Q7Z7G0
RYWAKLCYIDSQTDG	TUT4	501	Q5TAX3
LKAHKQGWCYRVYVL	PLD2	666	O14939
YQRWKSKLYSIVCGK	TNFRSF1A	236	P19438
KDGQLFCKKDYWARY	LIMK1	66	P53667